Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other ... be able to recycle empty pens at around 2,500 Boots, Lloyds ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

Novo Nordisk has announced billions of dollars worth of investments this year, including $4.1 billion to build a U.S. facility to fill injection pens for Wegovy and diabetes drug Ozempic.